文献速递糖尿病肥胖与代谢综合征

旧石器时代饮食联合运动对2型糖尿病肥胖患者肝脏与骨骼肌脂肪的异质性反应:随机对照试验

A heterogeneous response of liver and skeletal muscle fat to the combination of a Paleolithic diet and exercise in obese individuals with type 2 diabetes: a randomised controlled trial.
PubMed 文献 · Diabetologia · 2018-04-26

32例2型糖尿病肥胖患者随机接受旧石器时代饮食(PD组)或饮食联合监督运动(PD-EX组)12周,每组13例完成分析。两组体重中位数均下降7 kg,PD组肝脂肪降低74%而PD-EX组反应异质(组间P<0.05),PD组腓肠肌细胞内脂质降低40% vs PD-EX组降低22%(组间P<0.05),两组外周及脂肪组织胰岛素敏感性改善但肝胰岛素敏感性未改善。

要点

  • 旧石器时代饮食12周使2型糖尿病肥胖患者肝脂肪降低74%,加用运动后反应异质。
  • PD组腓肠肌细胞内脂质降低40%,PD-EX组降低22%,组间差异有统计学意义。
  • 两组外周及脂肪组织胰岛素敏感性改善,肝胰岛素敏感性均未改善。

核心结论

  • 旧石器时代饮食降低肝脂肪和腓肠肌细胞内脂质,加用运动训练后组织特异性反应异质。

研究设计与样本

  • 平行单盲随机对照试验,32例2型糖尿病、BMI 25-40 kg/m2、30-70岁患者接受旧石器时代饮食12周,随机分为监督联合运动训练组(PD-EX)或标准照护运动建议组(PD),每组13例完成分析。
  • 肝及外周胰岛素敏感性采用高胰岛素-正常血糖钳夹联合[6,6-2H2]葡萄糖输注测定,肝脂肪采用质子磁共振波谱评估,均为次要终点。
  • 骨骼肌细胞内脂质含量采用磁共振波谱作为次要分析测量,所有检查在瑞典于默奥大学医院完成。

主要发现

  • 两组体重中位数均下降7 kg,PD组脂肪量减少5.7 kg,PD-EX组减少6.5 kg。
  • 仅PD-EX组最大摄氧量增加。
  • PD组肝脂肪一致降低74%,PD-EX组反应异质(组间差异P<0.05)。
  • 腓肠肌细胞内脂质PD组降低40% vs PD-EX组降低22%(组间差异P<0.05)。
  • 两组外周及脂肪组织胰岛素敏感性改善,肝胰岛素敏感性未改善;PD组血浆胎球蛋白A降低11%(P<0.05),PD-EX组无变化;肝脂肪变化与胎球蛋白A变化相关(rS=0.63,P<0.01)。

关键数值与推荐

  • PD组肝脂肪降低74%,PD-EX组反应异质,组间P<0.05。
  • 腓肠肌细胞内脂质PD组降低40% vs PD-EX组降低22%,组间P<0.05。
  • PD组血浆胎球蛋白A降低11%(P<0.05),PD-EX组无变化。
  • 肝脂肪变化与胎球蛋白A变化相关(rS=0.63,P<0.01)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS/HYPOTHESIS: The aim of the study was to investigate ectopic fat deposition and insulin sensitivity, in a parallel single-blinded randomised controlled trial, comparing Paleolithic diet alone with the combination of Paleolithic diet and exercise in individuals with type 2 diabetes. METHODS: Thirty-two individuals with type 2 diabetes with BMI 25-40 kg/m2 and 30-70 years of age followed a Paleolithic diet ad libitum for 12 weeks. In addition, study participants were randomised by computer program to either supervised combined exercise training (PD-EX group) or standard care exercise recommendations (PD group). Staff performing examinations and assessing outcomes were blinded to group assignment. Thirteen participants were analysed in each group: hepatic and peripheral insulin sensitivity were measured using the hyperinsulinaemic-euglycaemic clamp technique combined with [6,6-2H2]glucose infusion, and liver fat was assessed by proton magnetic resonance spectroscopy; both analyses were secondary endpoints. Intramyocellular lipid (IMCL) content was measured by magnetic resonance spectroscopy as a secondary analysis. All examinations were performed at Umeå University Hospital, Umeå, Sweden. RESULTS: Both study groups showed a median body weight loss of 7 kg. Fat mass decreased by 5.7 kg in the PD group and by 6.5 kg in the PD-EX group. Maximum oxygen uptake increased in the PD-EX group only. Liver fat showed a consistent reduction (74% decrease) in the PD group, while the response in the PD-EX group was heterogeneous (p < 0.05 for the difference between groups). IMCL content of the soleus muscle decreased by 40% in the PD group and by 22% in the PD-EX group (p < 0.05 for the difference between groups). Both groups improved their peripheral and adipose tissue insulin sensitivity, but not their hepatic insulin sensitivity. Plasma fetuin-A decreased by 11% in the PD group (p < 0.05) and remained unchanged in the PD-EX group. Liver fat changes during the intervention were correlated with changes in fetuin-A (rS = 0.63, p < 0.01). Participants did not report any important adverse events caused by the intervention. CONCLUSIONS/INTERPRETATION: A Paleolithic diet reduced liver fat and IMCL content, while there was a tissue-specific heterogeneous response to added exercise training. TRIAL REGISTRATION: ClinicalTrials.gov NCT01513798 FUNDING: Swedish Diabetes Research Foundation, County Council of Västerbotten, Swedish Heart and Lung Foundation, King Gustav V and Queen Victoria's Foundation.

来源:Diabetologia,查看原文。版权归原作者所有。

引用

  1. Otten J, Stomby A, Waling M, et al. A heterogeneous response of liver and skeletal muscle fat to the combination of a Paleolithic diet and exercise in obese individuals with type 2 diabetes: a randomised controlled trial. Diabetologia. 2018. PMID: 29696296. doi:10.1007/s00125-018-4618-y

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。